Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.
Market Data
Essential tool: analyze, trade, manage, decide.
What’s Your Call?
Collective community sentiment on Mercury Laboratories Ltd
Your Vote -
Buy
33.33%
Hold
33.33%
Sell
33.33%
33.33%
3 users have voted
Option Chain
Analyzes market sentiment, predicts Mercury Laboratories Ltd' movement.
NO_RECORD_FOUND
News
Media spotlight triggers stock stock attention, sentiment.
-
Mercury Laboratories has submitted to BSE the Shareholding Pattern for the Period Ended December 31, 2025
-
Mercury Laboratories - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
-
Mercury Laboratories - Announcement under Regulation 30 (LODR)-Change in Management
-
Mercury Laboratories Q2 net profit zooms 228.00% at Rs 1.64 cr
-
Mercury Laboratories - Updates On New Small Volume Parenteral (Svps) Plant At Jarod
-
Mercury Laboratories - Unaudited Financial Results For The Quarter And Half Year Ended On September 2025
-
Mercury Laboratories - Board Meeting Outcome for Outcome Of Board Meeting Held On November 11, 2025
-
Mercury Laboratories - Announcement under Regulation 30 (LODR)-Change in Management
-
Mercury Laboratories - Board Meeting Intimation for Approval Of The Unaudited Financial Results For The Quarter And Half Year
-
Mercury Laboratories - Announcement under Regulation 30 (LODR)-Change in Management
Key fundamentals
Evaluate the intrinsic value of Mercury Laboratories Ltd stock
| Name | March-25 | March-24 | March-23 | March-22 | March-21 |
|---|---|---|---|---|---|
| Assets | 57.6628 | 56.3341 | 50.9931 | 45.4082 | 43.1344 |
| Liabilities | 57.6628 | 56.3341 | 50.9931 | 45.4082 | 43.1344 |
| Equity | 1.2 | 1.2 | 1.2 | 1.2 | 1.2 |
| Gross Profit | 7.0165 | 9.0303 | 8.5705 | 7.1145 | 9.5907 |
| Net Profit | 3.1449 | 5.6542 | 5.5788 | 3.6862 | 5.3374 |
| Cash From Operating Activities | 4.0011 | 8.225 | 2.4524 | 5.1505 | 8.2138 |
| NPM(%) | 4.18 | 7.48 | 7.4 | 6.36 | 7.78 |
| Revenue | 75.1012 | 75.559 | 75.3337 | 57.9238 | 68.6014 |
| Expenses | 68.0847 | 66.5287 | 66.7632 | 50.8093 | 59.0107 |
| ROE(%) | 5.64 | 10.14 | 10 | 6.61 | 9.57 |
Corporate Action
| XD-Date | Dividend-Amount | Dividend-% | Dividend Yield(%GE) | Price on that day |
|---|
Peers
Other companies within the same industry or sector that are comparable to Mercury Laboratories Ltd
| Company | Price | Price (% change) | pe(x) | EV/EBITDA(x) | ROE(%) | ROCE(%) |
|---|---|---|---|---|---|---|
| Albert David Ltd | 687.60 | 0.34 | 0.00 | 448.02 | 301.39 | 0.73 |
| Lotus Eye Hospital and Institute Ltd | 121.75 | -4.99 | 381.53 | 1632.51 | 3.55 | 0.00 |
| Bharat Immunological and Biologicals Corporation Ltd | 19.19 | 3.45 | 0.00 | 3389.63 | -39.50 | 0.00 |
| Astec Lifesciences Ltd | 591.60 | 4.87 | 0.00 | 1539.49 | -604.77 | 0.00 |
Company Info
The Company was incorporated on 12.02.1982, under the name and style of Mercury Laboratories Pvt. Limited. The promoters of the Company were MR. Kantilal Bapulal Shah & Mr. Ramanlal Bapulal Shah. Welcome to Mercury Laboratories Limited. For more than 6 decades, we have been at the forefront of formulating, developing, marketing and distributing safe, innovative and cost- effective pharmaceuticals that help to improve the quality of life of patients. In so doing, we have delivered long-term, profitable returns to our investors, value to our partners and rewarding career to our employees. We are mainly dedicated to Mother & Child Healthcare. We have state of the art modern manufacturing facility spread in 435600 sq. ft. (40,468 sq. mt.) of land. The technology delivers products like of international standards and specifications. The expertise of skilled and professional manpower ensures that the customers get new products & packaging as per need of their country and regulatory standards. At present, the facilities are up to the mark of the international standards and quality. We have separate manufacturing units for Tablets, Oral Liquids and Injections, small volume Parenteral & Ophthalmic Preparation. Mercury's manufacturing facilities is designed, equipped and operated to deliver high quality products within defined cost and delivery schedules. These manufacturing facilities have flexibility to operate in various dosage forms and wide range of batch sizes. The objective of the company is to manufacture all types of pharmaceutical formulations in the form of tablets, capsules, liquid orals, Injectables and Ointments. The Company became a Public Ltd. company on 15th May 1992 and its name was then changed to Mercury Laboratories Limited.2015-Mercury Laboratories is been listed in BSE.
The Company was incorporated on 12.02.1982, under the name and style of Mercury Laboratories Pvt. Limited. The promoters of the Company were MR. Kantilal Bapulal Shah & Mr. Ramanlal Bapulal Shah. Welcome to Mercury Laboratories Limited. For more than 6 decades, we have been at the forefront of formulating, developing, marketing and distributing safe, innovative and cost- effective pharmaceuticals that help to improve the quality of life of patients. In so doing, we have delivered long-term, profitable returns to our investors, value to our partners and rewarding career to our employees. We are mainly dedicated to Mother & Child Healthcare. We have state of the art modern manufacturing facility spread in 435600 sq. ft. (40,468 sq. mt.) of land. The technology delivers products like of international standards and specifications. The expertise of skilled and professional manpower ensures that the customers get new products & packaging as per need of their country and regulatory standards. At present, the facilities are up to the mark of the international standards and quality. We have separate manufacturing units for Tablets, Oral Liquids and Injections, small volume Parenteral & Ophthalmic Preparation. Mercury's manufacturing facilities is designed, equipped and operated to deliver high quality products within defined cost and delivery schedules. These manufacturing facilities have flexibility to operate in various dosage forms and wide range of batch sizes. The objective of the company is to manufacture all types of pharmaceutical formulations in the form of tablets, capsules, liquid orals, Injectables and Ointments. The Company became a Public Ltd. company on 15th May 1992 and its name was then changed to Mercury Laboratories Limited.2015-Mercury Laboratories is been listed in BSE.
Read More
Parent Organisation
Mercury Laboratories Ltd.
Founded
12/02/1982
Managing Director
Mr.Rajendra R Shah
NSE Symbol
FAQ
The current price of Mercury Laboratories Ltd is
The 52-week high for Mercury Laboratories Ltd is
The market capitalization of Mercury Laboratories Ltd is currently This value can fluctuate based on stock price movements and changes in the number of shares outstanding.
To buy Mercury Laboratories Ltd shares, you need to have a brokerage account. First, choose a reputable brokerage firm, open an account, and complete the necessary KYC procedures.
To invest in Mercury Laboratories Ltd, you need a brokerage account. After opening an account and completing the KYC process, you can fund your account and use the trading platform to purchase Mercury Laboratories Ltd shares.
The CEO of Mercury Laboratories Ltd is Mr.Rajendra R Shah, who has been leading the company with a vision to expand its renewable energy portfolio and drive sustainable growth.